ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 118 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $373,860 | -19.8% | 124,620 | 0.0% | 0.00% | – |
| Q2 2023 | $466,079 | +55.5% | 124,620 | +39.2% | 0.00% | – |
| Q1 2023 | $299,825 | -26.9% | 89,500 | +4.9% | 0.00% | – |
| Q4 2022 | $410,293 | -10.0% | 85,300 | +6.5% | 0.00% | – |
| Q3 2022 | $456,000 | -19.9% | 80,100 | 0.0% | 0.00% | – |
| Q2 2022 | $569,000 | -1.6% | 80,100 | 0.0% | 0.00% | – |
| Q1 2022 | $578,000 | -19.0% | 80,100 | +0.3% | 0.00% | – |
| Q4 2021 | $714,000 | -78.9% | 79,900 | -17.0% | 0.00% | -100.0% |
| Q3 2021 | $3,376,000 | +75.0% | 96,288 | +7.2% | 0.00% | 0.0% |
| Q2 2021 | $1,929,000 | +66.1% | 89,800 | +377.6% | 0.00% | 0.0% |
| Q1 2021 | $1,161,000 | +118.6% | 18,802 | +48.0% | 0.00% | – |
| Q4 2020 | $531,000 | – | 12,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |